121 related articles for article (PubMed ID: 8016899)
21. Randomized study of concurrent carboplatin, paclitaxel, and radiotherapy with or without prior induction chemotherapy in patients with locally advanced non-small cell lung cancer.
Gouda YS; Kohail HM; Eldeeb NA; Omar AM; El-Geneidy MM; Elkerm YM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):73-81. PubMed ID: 17237853
[TBL] [Abstract][Full Text] [Related]
22. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
23. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
24. Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
Capelan M; Roda D; Geuna E; Rihawi K; Bodla S; Kaye SB; Bhosle J; Banerji U; O'Brien M; de Bono JS; Popat S; Yap TA
Lung Cancer; 2017 Sep; 111():6-11. PubMed ID: 28838399
[TBL] [Abstract][Full Text] [Related]
25. Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
Su SF; Hu YX; Ouyang WW; Lu B; Ma Z; Li QS; Li HQ; Geng YC
BMC Cancer; 2013 Oct; 13():474. PubMed ID: 24118842
[TBL] [Abstract][Full Text] [Related]
26. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer.
Imai K; Nakagawa T; Matsuzaki I; Orino K; Saito H; Sato K; Sano M; Nakayama K; Sato Y; Motoyama S; Nomura K; Shibata H; Minamiya Y
Surg Today; 2019 Aug; 49(8):678-685. PubMed ID: 30826861
[TBL] [Abstract][Full Text] [Related]
29. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
[TBL] [Abstract][Full Text] [Related]
30. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
Jørgensen N; Meline EL; Jeppesen SS; Hansen O; Nielsen M; Schytte T
Acta Oncol; 2019 Oct; 58(10):1393-1398. PubMed ID: 31271075
[No Abstract] [Full Text] [Related]
31. Failure patterns of combined modality treatment in lung cancer: the impact of staging.
Hoekstra CJ; Rijna H; Smit EF; Van Mourik JC; Postmus PE; Lammertsma AA; Hoekstra OS
Neth J Med; 2002 Mar; 60(1):17-21. PubMed ID: 12074038
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
[TBL] [Abstract][Full Text] [Related]
33. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
34. Clinical study of systemic chemotherapy combined with bronchoscopic interventional cryotherapy in the treatment of lung cancer.
Xu F; Song J; Xu B; Wang J; Mao J; Liu H; Li X; Deng A
BMC Cancer; 2020 Nov; 20(1):1089. PubMed ID: 33176740
[TBL] [Abstract][Full Text] [Related]
35. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
36. Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.
Adelstein DJ; Rice TW; Rybicki LA; Greskovich JF; Ciezki JP; Carroll MA; DeCamp MM
Lung Cancer; 2002 May; 36(2):167-74. PubMed ID: 11955651
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
Sher DJ; Fidler MJ; Liptay MJ; Koshy M
Lung Cancer; 2015 Jun; 88(3):267-74. PubMed ID: 25862147
[TBL] [Abstract][Full Text] [Related]
39. Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure.
Reddy S; Lee MS; Bonomi P; Taylor SG; Kaplan E; Gale M; Faber LP; Warren W; Kittle CF; Hendrickson FR
Int J Radiat Oncol Biol Phys; 1992; 24(1):17-23. PubMed ID: 1324896
[TBL] [Abstract][Full Text] [Related]
40. Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approach.
Stupp R; Betticher D; Ris HB; Peters S; Pless M
J Clin Oncol; 2011 Feb; 29(5):e118-9; author reply e120. PubMed ID: 21205753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
